Dynavax Technologies (NASDAQ:DVAX – Get Free Report) announced its earnings results on Wednesday. The biopharmaceutical company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.14 by $0.07, Zacks reports. The company had revenue of $94.88 million for the quarter, compared ... Read more
Watch List News - Nov 07
A troubled Indiana contract manufacturing plant recently acquired by Novo Nordisk is considered to not be in compliance with FDA standards Read more
Stat - Oct 14
